Clinical Trial Update: Bioavailability of Doravirine (MK-1439) Experimental Nano Formulations in Healthy Adults (MK-1439-046) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating bioavailability of experimental nano formulations of doravirine (MK-1439) in healthy adults has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Doravirine (doravirine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Human Immunodeficiency Virus-1 (HIV-1) | Phase 1 | Status: COMPLETED | Results posted: 2019-02-22